Regional Fish Institute Ltd. in Japan is now accepting orders on a crowdfunding site for genetically manipulated farmed red sea bream that boasts 1.2 times thicker flesh than ordinary farmed ones.
Sales are initially restricted to 190 customers with deliveries expected to start in October. The production process is explained in detail with each purchase.
Kyoto University and Kindai University developed the fleshier fish variant by rendering a gene called myostatin that controls muscle growth.
The Regional Fish Institute, a biotech enterprise affiliated with Kyoto University, registered the commercialization of its “genome-edited food” with the government on Sept. 17.
On the same day, the health ministry declared that no safety examinations were required.
Genome editing, which aims to destroy or introduce particular genes, is also applied for increasing harvest yields in rice and other plant varieties.
As no foreign genes from other species were introduced into genome-processed items, as with genetic recombination, no safety checks were necessary.
This method is essentially the same as traditional selective breeding methods to create improved varieties.
The institute's sea bream is the first genome-edited animal product to be marketed in Japan.


BOJ’s Himino Signals Timely Rate Hikes as Inflation Risks Rise
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Trump Administration Releases New UFO Files and Apollo Mission Records
Gold Prices Fall as Stronger Dollar, Fed Rate Outlook Weigh
Fed Chair Warsh Faces Key Jackson Hole Test
NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Hong Kong Home Prices Fall 0.5% in July, Ending Long Winning Streak
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Asian Stocks Mixed as KOSPI Falls Ahead of Fed Speech
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
China vs. NASA: The New Moon Race and What's at Stake by 2030
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Gold Prices Slip Ahead of Fed Chair Warsh Speech
Gold Prices Rise Toward $4,650 Ahead of Warsh’s Jackson Hole Speech
German Industry Pushes Merz for Tougher China Trade Policy 



